An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
17 Sep 2020	Submitted	Original manuscript
21 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
22 Sep 2020	Editorially accepted
13 Oct 2020	Article published	10.1186/s13063-020-04766-5

Back to article page